Top U.S. academic life science researchers report near universal interest in translating their innovations to bring more cures to market, yet the majority also want external resources and allies for the journey, reports the 2024 Cure Translational Research Survey.

Fueling Engines of Innovation Image Asset

Fueling Engines of Innovation Image

Fueling Engines of Innovation

The U.S. National Institutes of Health is the largest single public funder of biomedical and behavioral research in the world. NIH activities and funding are major drivers of the United States’ competitive advantage in science and technology. The U.S. Congress is the primary funder of NIH via annual appropriations from the federal budget.

Impacts of NIH Funding on the US Economy, Jobs and Better Health

Blue

The EU’s top health official said reforms will make Europe more attractive for drug developers as FDA changes create industry uncertainty.

Europe Makes Bold Bid to Attract Biotech Amid FDA Uncertainty

The shortage of anti-obesity medications is sending patients to gray markets while healthcare innovators look for longer-term solutions beyond of GLP-1s.

How Entrepreneurs are Looking Beyond GLP-1s for Obesity Innovations

When VCs say no, founders are tapping alternative sources, from academic accelerators and angel investors to strategic industry partnerships and mission-aligned family offices, to bring solutions to market.


Beyond VC: 6 Ways to Fund Your Healthcare Startup

NYU Langone’s Marc Sedam shares how, amid sweeping federal cuts to scientific research, some U.S. universities are quietly rewriting the funding playbook for moving discoveries from lab to market.

Marc Sedam NYU Langone Thumbnail Image

Universities Step Up as Translational Funders Amid NIH Uncertainty

CEO Mary Beth Cicero says women’s health startups face hurdles even with novel ideas and real-world demand.

Mary Beth Cicero 3 Daughters Thumbnail Image

Breakthrough IUD Faces Familiar Funding Barrier in Women’s Health

Healthcare industry executives at BIO paint a picture of optimism for the sector's future amid policy changes and technological disruptions.

6 executives Betty Woo, PhD  and Daniella Cramp image

6 Executives on How Resilience, Not Retreat, Defines the Healthcare Year Ahead

Entrepreneurs Jenny Carillo, Roya Pakzad, and Mike Satow advise on how to healthcare companies can prepare for acquisitions, from bankers and buyers to IP and partnerships. 

How to Exit Smart:  7 Mistakes Healthcare Founders Should Avoid 

As biopharmas report first quarter earnings, executives are being asked to respond to the Trump administration’s many changes to the business environment, regulatory scene and domestic manufacturing.

Drugmakers Brace for Trump-Era Shifts on Tariffs, Manufacturing and Regulation

During the 2025 XSeed Award ceremony, a panel of biotech investors, policy experts, and founders offered hard-earned advice to early-stage entrepreneurs navigating a volatile funding landscape.

Experts Urge Healthcare Startups to Stay Bold, Focused, and Patient-Centered

Two NYC-based startups, GenKardia and Sidereal Therapeutics, have each won a $250,000 XSeed Award to support moving promising preclinical research of novel therapies for kidney and heart disease forward toward commercialization.

$250K XSeed Awards Granted to Minority- and Women-Led Startups Advancing New Drugs 

While the Trump administration slashes government grants to early-stage research that has played a critical role in drug development, researchers provide advice on how to influence government representatives to push back.

Mayhem, Destruction and Biomedical Tumult from Trump Cuts

LunaJoy, a mental health provider for women, won the Impact Challenge at Cure's Power of X Summit, securing $110,000 in funding and services to help address the critical gap in women’s healthcare innovation.

LunaJoy Wins Impact Challenge at Power of X Summit article image

LunaJoy Wins Impact Challenge at Power of X Summit

LunaJoy Wins Impact Challenge at Cure's Power of X Summit

Former FDA Commissioner Margaret Hamburg, MD, discusses the impact of federal layoffs, the erosion of public trust in science, and the risks of undermining U.S. leadership in biomedical research. 


Federal Layoffs Deeply Concern Former FDA Commissioner image

Federal Layoffs Deeply Concern Former FDA Commissioner

Lime Therapeutics Pioneers Therapies Targeting Lipid Biology image

Lime Therapeutics Pioneers Therapies Targeting Lipid Biology

Biotech wasn’t sure what to expect under a second Trump term. Industry leaders and analysts predict policy shifts could benefit innovation and drug pricing reform.

Biotech’s Surprising Policy Boost Under Trump image

Biotech’s Surprising Policy Boost Under Trump

Academic institutions and industry leaders are forging new pathways to commercialize cutting-edge research.

Universities and Industry Join Forces to Advance Innovation image

Universities and Industry Join Forces to Advance Innovation

Venture capital firms are playing a key role in funding healthcare innovations, but uncertainty surrounding changing economic conditions and regulatory policies adds complexity to the path forward.

thumbnail_dna_icons_dollars_GTY1304606878

Five Trends VCs Predict Will Shape the Future of Medicine

CIF, part of a growing sector of venture funds that invest for social good, is a non-profit that practices regenerative philanthropy.


Catalytic Impact Foundation Funds Action in Women’s Health image

CIF Funds Action in Women’s Health 

Angel investor and pharma industry executive-turned-consultant Shwen Gwee has worked with startups for more than 15 years, garnering insights for biopharma entrepreneurs.

5 Startup Funding Tips from Angel Investor Shwen Gwee

José Manuel (Manny) Otero, PhD, Chief Technical Officer at Lexeo Therapeutics shares a roadmap for early-stage biotechs.

Biotech Expert Manny Otero, PhD, on Trends Shaping Startups

The legislation could prohibit U.S. pharmaceutical and biotechnology companies from contracting with certain Chinese companies.

thumbnail_medical_innovation_concept_GTY-609945312

Will the BIOSECURE Act Stall Biopharma Progress?

Evommune, Inc., a clinical-stage biotech and Cure Collaboration Residency company, secured $115 million in Series C financing, underscoring its pioneering approach to developing novel therapies for chronic inflammatory diseases.

Evommune $115M Series C Funding Fuels Innovation in Chronic Inflammation

The annual BioGENEius Challenge, an esteemed competition for young talent in biotechnology from across the US, announced its 2024 winner, which Cure sponsored.

Yifan Ding Wins 2024 BioGENEius Challenge Sponsored by Cure

Neuropharmacology and drug delivery expert Ashiwel Undieh, PhD, shares how his 2021 XSeed Award accelerated and enables his research. 

thumbnail-ashiwel-undieh

One Unrestricted Grant Yields Multiple Opportunities for Health

Teams led by Carol M. Troy, MD, PhD, of Columbia University Medical Center, and Paraskevi Giannakakou, PhD, of Weill Cornell Medical College, each received $250,000 grants as winners of the fourth annual XSeed Award.

thumbnail-xseed2024-winners-carol-evie

Troy, Giannakakou Named 2024 XSeed Award Winners

Life Science Sherpas helps venture-backed companies create connections and foster deals via networking. 

Life Science Sherpas

Life Science Sherpas Fosters Connections and Deal-Making

Life science startups may be cash-strapped, but stock-based awards may be just the ticket to create competitive employee compensation packages.

thumbnail-equity-article

5 Equity Awards Life Science Startups Use to Incentivize Talent

Melissa Wallace launched Fierce Foundry in 2023 to build companies that not only improve the lives of women, but create a new investment flywheel for female founders.

thumbnail-tuesday-talks-fierce-foundry-melissa-wallace

Fierce Foundry’s Innovative Approach to Funding and Accelerating FemTech

Joe Shonkwiler, MD, MBA, COO of ARPA-H, explains how the agency is accelerating better health outcomes for everyone by supporting development of high-impact solutions to society's most challenging health problems.



AI-Powered Companies Dominate 2025 Digital Health Funding

Cure’s Landmark Report Reveals 87% of Healthcare Leaders Remain Optimistic About Future, Despite Challenges

Your Home in NYC

November 11 -13 , 2025

Cure Presents: The X Factor Healthcare Innovation Summit

Accelerating Advances in Health

Funding and Models

Insights

Recommended Topics

Join our community